Well the extensions of deals have to be getting close unless it's in referance to a new larger agreement with one of the existing partners then at has to be either Roche or Mediimune moving forward to the next stage. I guess NAOS really is still in the same position as everyone though only running off anticipated timelines it's all out of the companys control & reliant on the partners. FWIW NAOS's expected developments July/August has been the same since start of year.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.000(0.00%) |
Mkt cap ! $839.8M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.42 | $3.475M | 2.414M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55564 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 6099 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |